Respiratory syncytial virus sends thousands to the hospital every year and can be fatal for the very young and old — but there is no treatment. Professor Richard Plemper is working to change that.
Leaking from a faulty furnace or fireplace, carbon monoxide gas can kill. But scientists are finding that — given in small, targeted doses — it also has the power to treat illnesses ranging from cancer to sickle cell disease to traumatic brain injury. How one Georgia State professor is working to unleash the molecule’s healing benefits.
Kate Kroell (MPH, '11) sees accessibility to fresh foods as a public health issue and a matter of social justice.
Adding highly refined fiber to processed foods could have negative effects on human health, such as promoting liver cancer, according to a new study by researchers at Georgia State University and the University of Toledo.
Cesarean-born mice show altered patterns of cell death across the brain, exhibiting greater nerve cell death than vaginally delivered mice in at least one brain area, a finding by Georgia State University researchers that suggests birth mode may have acute effects on human neurodevelopment that may lead to long-lasting changes in the brain and behavior.
Assistant professor Laura Shannonhouse will be the principal investigator on a two-year, $699,362 grant from the U.S. Department of Health and Human Services to conduct research on preventing suicide and promoting life with older adults.
Georgia State University has signed a licensing agreement with DaZen Theranostics Inc., a Delaware-based start-up company, to develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells during diagnostic imaging and deliver a therapeutic drug to destroy cancerous cells.
Vince Calhoun, one of the world’s foremost experts in brain imaging and analysis, has been named the founding director of the Center for Translational Research in Neuroimaging and Data Science (TReNDS) at Georgia State University.
Researchers have identified how a viral protein, which plays a major role in causing deadly Nipah and Hendra virus infections, targets a critical function in human cells to suppress immune responses and promote fatal disease.
Georgia State University has received a five-year, $2.2 million grant to develop combination therapies for respiratory syncytial virus, or RSV, and related respiratory viruses.
